ArticleHepatology international2022

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study.

Takeshi Hatanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.